One huge reason why the world of medicine hasn't yet found "the cure" for hard-to-treat malignancies like acute myeloid ...

The US Patent and Trademark Office will issue BIAF a new patent on its flow cytometry+AI platform that detects lung cancer as ...

We recommend that CTC should be routinely assessed and measured at diagnosis as part of risk evaluation,” study researchers wrote.

BostonGene’s Foundation Model of Cancer and the Immune System–Led Approach Recognized for Advancing Precision Oncology and De-Risking Drug Development for BiopharmaWALTHAM, Mass.--(BUSINESS ...

Scientists have developed a cancer vaccine that stopped three different types of aggressive tumors from growing in mice.

What happens when pharma and flow cores face the same challenge — doing more with less?​ Join Ryan Duggan (AbbVie) and David ...

A New Era in High-Throughput Flow Cytometry In today’s fast-paced drug discovery and screening environments, speed, prec | ...

Affinity Technologies, Inc. ( ($BIAF) ) has issued an update. On October 16, 2025, bioAffinity Technologies, Inc. announced it received a ...

An 82-year-old woman with a history of congestive heart failure was admitted to this hospital for volume overload. Ascites, ...

SAN ANTONIO, October 20, 2025--bioAffinity Technologies will present research related to its noninvasive CyPath Lung test for ...

Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...